Publications by authors named "C Assaf"

Claim this Profile
R
Recent trends of incidence and mortality of cutaneous lymphomas in Germany.
Khodr Cheikh El Najjarine, Hiltraud Kajüter, Ina Wellmann, Andreas Stang, Chalid Assaf

J Dtsch Dermatol Ges· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy combined with antibody-drug conjugate-induced radiosensitization leads to long-term remission in mycosis fungoides.
Mathias Oymanns, Khaled Elsayad, Michael Daum-Marzian, Raed Abu-Dawud, Marjan Motiei, Chalid Assaf

Br J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.
Christoph Blazejak, Mathias Oymanns, René Stranzenbach, Uwe Hillen, Christina Mitteldorf, Chalid Assaf

Cancers (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a truly 'benign' disease?
Ulrike Wehkamp, Chalid Assaf

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP': Journal of Investigative Dermatology, Volume 130, Issue 3, March 2010, Pages 826-840.
Frank K Braun, Burkhard Hirsch, Nadya Al-Yacoub, Horst Dürkop, Chalid Assaf

J Invest Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis